# OnCo record acrotech-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/acrotech-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "acrotech-biopharma" ;
  schema:name "Acrotech Biopharma"@en ;
  schema:description "Acrotech Biopharma, part of Aurobindo, owns the former Spectrum Pharmaceuticals haematology portfolio: the radioimmunotherapy Zevalin, pralatrexate (Folotyn), belinostat (Beleodaq) and vincristine liposome (Marqibo)."@en ;
  schema:url <https://onco.cc/companies/acrotech-biopharma/>, <https://www.acrotechbiopharma.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.acrotechbiopharma.com> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/ibritumomab-tiuxetan/>, <https://onco.cc/drugs/pralatrexate/>, <https://onco.cc/drugs/belinostat/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/melphalan/> ;
  onco:trials <https://onco.cc/trials/nct06072131/> .